Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127600301 | 12760030 | 1 | I | 20160907 | 20160919 | 20160919 | EXP | GB-TEVA-692561ACC | TEVA | 0.00 | M | Y | 0.00000 | 20160919 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127600301 | 12760030 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Oral | N | U | 77769 | TABLET | ||||||||
127600301 | 12760030 | 2 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | DOSAGE FORM: UNSPECIFIED | U | U | 76000 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127600301 | 12760030 | 1 | Bipolar disorder |
127600301 | 12760030 | 2 | Bipolar disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127600301 | 12760030 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127600301 | 12760030 | Apathy | |
127600301 | 12760030 | Emotional disorder | |
127600301 | 12760030 | Mental impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |